Showing 1 - 15 results of 15 for search 'Tackley, G', query time: 0.03s
Refine Results
-
1
-
2
Magnetic resonance imaging in neuromyelitis optica. by Tackley, G, Kuker, W, Palace, J
Published 2014Journal article -
3
Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status by Kong, Y, Okoruwa, H, Revis, J, Tackley, G, Leite, M, Lee, M, Tracey, I, Palace, J
Published 2016Journal article -
4
-
5
-
6
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis by Jurynczyk, M, Geraldes, R, Probert, F, Woodhall, M, Waters, P, Tackley, G, De Luca, G, Chandratre, S, Leite, M, Vincent, A, Palace, J
Published 2017Journal article -
7
Neuromyelitis optica relapses: race and rate, immunosuppression and impairment by Tackley, G, O'Brien, F, Rocha, J, Woodhall, M, Waters, P, Chandratre, S, Halfpenny, C, Hemingway, C, Wassmer, E, Wasiewski, W, Leite, M, Palace, J
Published 2016Journal article -
8
Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis by Tackley, G, Vecchio, D, Hamid, S, Jurynczyk, M, Kong, Y, Gore, R, Mutch, K, Woodhall, M, Waters, P, Vincent, A, Leite, M, Tracey, I, Jacob, A, Palace, J
Published 2016Journal article -
9
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tis... by Tackley, G, Kong, Y, Minne, R, Messina, S, Winkler, A, Cavey, A, Everett, R, DeLuca, GC, Weir, A, Craner, M, Tracey, I, Palace, J, Stagg, CJ, Emir, U
Published 2021Journal article -
10
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease by Waters, P, Woodhall, M, O'Connor, K, Reindl, M, Lang, B, Sato, D, Juryńczyk, M, Tackley, G, Rocha, J, Takahashi, T, Misu, T, Nakashima, I, Palace, J, Fujihara, K, Leite, M, Vincent, A
Published 2015Journal article -
11
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. by Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J
Published 2017Journal article -
12
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease by Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J
Published 2017Journal article -
13
Clinical presentation and prognosis in MOG-antibody disease: a UK study by Jurynczyk, M, Messina, S, Woodhall, M, Raza, N, Everett, R, Roca-Fernandez, A, Tackley, G, Hamid, S, Sheard, A, Reynolds, G, Chandratre, S, Hemmingway, C, Jacob, A, Vincent, A, Leite, M, Waters, P, Palace, J
Published 2017Journal article -
14
Disease course and disability outcomes in MOG-antibody disease in the UK by Jurynczyk, M, Messina, S, Woodhall, M, Raza, N, Everett, R, Roca-Fernandez, A, Tackley, G, Hamid, S, Sheard, A, Reynolds, G, Chandratre, S, Hemingway, C, Jacob, A, Vincent, A, Leite, M, Waters, P, Palace, J
Published 2017Conference item -
15
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease by Juryńczyk, M, Tackley, G, Kong, Y, Geraldes, R, Matthews, L, Woodhall, M, Waters, P, Kuker, W, Craner, M, Weir, A, DeLuca, G, Kremer, S, Leite, M, Vincent, A, Jacob, A, de Sèze, J, Palace, J
Published 2016Journal article